Quantcast

Latest Oncolin Therapeutics Inc. Stories

2010-09-14 07:57:00

HOUSTON, Sept. 14 /PRNewswire/ -- Bering Exploration, Inc., formerly Oncolin Therapeutics, Inc., (OTC Bulletin Board: OCOL) announced today that it has begun drilling on its South Texas oil and gas prospect that has potential gross reserves of 5,000,000 barrels of oil and 46BCF of natural gas. The initial well will be drilled to approximately 10,000 feet to test the Oligocene Frio trend in South Chambers County, Texas. Bering's interest is a 5% working interest after pay out in this...

2010-09-13 05:00:00

HOUSTON, Sept. 13 /PRNewswire/ -- Bering Exploration, Inc., formerly Oncolin Therapeutics, Inc., (OTCBB: OCOL) announced today that it has acquired an interest in a South Texas oil and gas prospect that has potential gross reserves of 5,000,000 barrels of oil and 46 BCF of natural gas. The initial well will be drilled to approximately 10,000 feet to test the Oligocene Frio trend in South Chambers County, Texas. Bering's interest is a 5% working interest after pay out in this prospect....

2008-06-30 09:03:37

Oncolin Therapeutics, Inc., (OTCBB:OCOL) announces that a team of scientists supported by an Oncolin Sponsored Research Agreement (SRA) and lead by Professor Waldemar Priebe from The University of Texas M. D. Anderson Cancer Center (UTMDACC) has discovered a new inhibitor of glycolysis, which is superior to the other known inhibitors. These results were confirmed both in vitro as well as in vivo brain tumor models. These new results have demonstrated that the compound that Oncolin in...

2008-06-24 02:30:29

Oncolin Therapeutics, Inc., (OTCBB:OCOL) is very pleased to announce that Dr. Daniel Von Hoff has joined the company's Scientific Advisory Board (SAB). Dr. Von Hoff is generally considered to be one of the world's leading experts in oncology drug development and is an advisor in some capacity to a large number of oncology companies. Dr. Von Hoff was appointed to President Bush's National Cancer Advisory Board in June 2004. Dr. Von Hoff is the past President of the American Association...

2008-06-19 09:01:11

Oncolin Therapeutics, Inc., (OTCBB:OCOL) is pleased to announce that a group of scientists lead by Professor Waldemar Priebe from The University of Texas M. D. Anderson Cancer Center (UTMDACC) will be presenting its lead cancer technology at this prestigious symposium in Geneva Switzerland in October 2008. Targeted initially for brain tumors, this technology is a major breakthrough in inhibiting glycolysis, a process many tumor cells, but not normal cells, require for growth and survival....


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related